ZHU:CA:TSX-BMO Equal Weight US Health Care Index ETF (CAD)

ETF | Sector Equity |

Last Closing

CAD 45.61

Change

-1.07 (-2.29)%

Market Cap

CAD 0.01B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-05 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.12 (+0.26%)

CAD 3.39B
ZWU:CA BMO Covered Call Utilities ETF

+0.10 (+0.94%)

CAD 1.82B
XIT:CA iShares S&P/TSX Capped Informa..

+2.16 (+2.87%)

CAD 0.78B
TXF:CA First Asset Tech Giants Covere..

+0.11 (+0.51%)

CAD 0.66B
HTA:CA Harvest Tech Achievers Growth ..

+0.11 (+0.56%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

+0.86 (+1.25%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

+0.18 (+0.86%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

+0.31 (+1.13%)

CAD 0.40B
CWW:CA iShares Global Water Common Cl..

-0.01 (-0.02%)

CAD 0.30B
COW:CA iShares Global Agriculture Com..

-1.11 (-1.66%)

CAD 0.28B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.70% 71% C- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.70% 71% C- 83% B
Trailing 12 Months  
Capital Gain 7.09% 40% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.09% 31% F 28% F
Trailing 5 Years  
Capital Gain 30.31% 46% F 61% D-
Dividend Return 2.26% 15% F 4% F
Total Return 32.57% 31% F 48% F
Average Annual (5 Year Horizon)  
Capital Gain 4.60% 37% F 48% F
Dividend Return 4.63% 29% F 43% F
Total Return 0.03% 9% A- 3% F
Risk Return Profile  
Volatility (Standard Deviation) 11.17% 80% B- 70% C-
Risk Adjusted Return 41.45% 31% F 52% F
Market Capitalization 0.01B 12% F 10% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.